{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,16]],"date-time":"2026-08-16T20:08:04Z","timestamp":1786910884303,"version":"build-2736575974"},"reference-count":61,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000030","name":"Institute of Genetics","doi-asserted-by":"publisher","award":["SBI-167982"],"award-info":[{"award-number":["SBI-167982"]}],"id":[{"id":"10.13039\/501100000030","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008582","name":"McGill University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008582","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","lipidjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Lipidology"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.jacl.2021.11.014","type":"journal-article","created":{"date-parts":[[2021,12,6]],"date-time":"2021-12-06T12:30:01Z","timestamp":1638793801000},"page":"52-65","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Health-related quality of life in homozygous familial hypercholesterolemia: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"16","author":[{"given":"Latifah","family":"Alothman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6558-9475","authenticated-orcid":false,"given":"Alexandre M","family":"B\u00e9langer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Ruel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liam R","family":"Brunham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsay","family":"Hales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques","family":"Genest","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6959-392X","authenticated-orcid":false,"given":"Leo E","family":"Akioyamen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacl.2021.11.014_bib0001","doi-asserted-by":"crossref","first-page":"2553","DOI":"10.1016\/j.jacc.2020.03.057","article-title":"Worldwide prevalence of familial hypercholesterolemia: meta-analyses of 11 million subjects","volume":"75","author":"Beheshti","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacl.2021.11.014_bib0002","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1161\/CIRCULATIONAHA.119.044795","article-title":"Prevalence of familial hypercholesterolemia among the general population and patients with atherosclerotic cardiovascular disease","volume":"141","author":"Hu","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.jacl.2021.11.014_bib0003","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1093\/eurheartj\/ehu274","article-title":"Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the consensus panel on familial hypercholesterolaemia of the European atherosclerosis society","volume":"35","author":"Cuchel","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacl.2021.11.014_bib0004","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1161\/CIRCULATIONAHA.111.042523","article-title":"Reduction in mortality in subjects with homozygous familial hypercholesterolemia associated with advances in lipid-lowering therapy","volume":"124","author":"Raal","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.jacl.2021.11.014_bib0005","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1093\/eurheartj\/ehx317","article-title":"Survival in homozygous familial hypercholesterolaemia is determined by the on-treatment level of serum cholesterol","volume":"39","author":"Thompson","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacl.2021.11.014_bib0006","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1097\/01.mol.0000137222.23784.2a","article-title":"Current management of severe homozygous hypercholesterolaemias","volume":"15","author":"Naoumova","year":"2004","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.jacl.2021.11.014_bib0007","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1016\/S0140-6736(11)61476-1","article-title":"Homozygous familial hypercholesterolaemia","volume":"379","author":"Macchiaiolo","year":"2012","journal-title":"Lancet Lond Engl"},{"key":"10.1016\/j.jacl.2021.11.014_bib0008","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.ijcard.2013.11.025","article-title":"Integrated guidance on the care of familial hypercholesterolaemia from the International FH Foundation","volume":"171","author":"Watts","year":"2014","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacl.2021.11.014_bib0009","first-page":"1553","article-title":"Canadian cardiovascular society position statement on familial hypercholesterolemia: update 2018","volume":"34","author":"Brunham","year":"2018","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.jacl.2021.11.014_bib0010","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1016\/j.jacc.2017.06.058","article-title":"Efficacy of rosuvastatin in children with homozygous familial hypercholesterolemia and association with underlying genetic mutations","volume":"70","author":"Stein Evan","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacl.2021.11.014_bib0011","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1172\/JCI200318925","article-title":"Monogenic hypercholesterolemia: new insights in pathogenesis and treatment","volume":"111","author":"Rader","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jacl.2021.11.014_bib0012","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.jacl.2011.04.003","volume":"5","author":"Goldberg","year":"2011","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.jacl.2021.11.014_bib0013","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1097\/MOL.0000000000000234","article-title":"Lipoprotein apheresis: present and future uses","volume":"26","author":"Moriarty","year":"2015","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.jacl.2021.11.014_bib0014","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.ecl.2015.09.003","volume":"45","author":"Moriarty","year":"2016","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1016\/j.jacl.2021.11.014_bib0015","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s11883-014-0465-6","article-title":"Lipoprotein apheresis in the management of familial hypercholesterolaemia: historical perspective and recent advances","volume":"17","author":"Stefanutti","year":"2015","journal-title":"Curr Atheroscler Rep"},{"key":"10.1016\/j.jacl.2021.11.014_bib0016","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1194\/jlr.R056549","article-title":"Lipoprotein apheresis to treat elevated lipoprotein (a)","volume":"57","author":"Waldmann","year":"2016","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jacl.2021.11.014_bib0017","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1111\/j.1537-2995.2009.02135.x","article-title":"Aorta and coronary angiographic follow-up of children with severe hypercholesterolemia treated with low-density lipoprotein apheresis","volume":"49","author":"Stefanutti","year":"2009","journal-title":"Transfusion (Paris)"},{"key":"10.1016\/j.jacl.2021.11.014_bib0018","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1016\/S0002-9149(98)00692-4","article-title":"Long-term efficacy of low-density lipoprotein apheresis on coronary heart disease in familial hypercholesterolemia. Hokuriku-FH-LDL-apheresis study group","volume":"82","author":"Mabuchi","year":"1998","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacl.2021.11.014_bib0019","doi-asserted-by":"crossref","DOI":"10.1007\/s11883-019-0787-5","article-title":"Current role of lipoprotein apheresis","volume":"21","author":"Thompson","year":"2019","journal-title":"Curr Atheroscler Rep"},{"key":"10.1016\/j.jacl.2021.11.014_bib0020","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1016\/j.jacl.2018.05.008","article-title":"Treatment-related and health-related quality of life in lipoprotein apheresis patients","volume":"12","author":"De Gucht","year":"2018","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.jacl.2021.11.014_bib0021","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.jacl.2015.12.009","article-title":"Quality of life in patients treated with lipoprotein apheresis","volume":"10","author":"Rosada","year":"2016","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.jacl.2021.11.014_bib0022","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1097\/PSY.0b013e3181dbff97","article-title":"Prognostic association of anxiety post myocardial infarction with mortality and new cardiac events: a meta-analysis","volume":"72","author":"Roest","year":"2010","journal-title":"Psychosom Med"},{"key":"10.1016\/j.jacl.2021.11.014_bib0023","article-title":"Health-related quality of life and long-term morbidity and mortality in patients hospitalised with systolic heart failure","volume":"3","author":"Berg","year":"2014","journal-title":"JRSM Cardiovasc Dis"},{"key":"10.1016\/j.jacl.2021.11.014_bib0024","doi-asserted-by":"crossref","first-page":"215","DOI":"10.4330\/wjc.v7.i4.215","article-title":"Effective treatment of depression improves post-myocardial infarction survival","volume":"7","author":"Banankhah","year":"2015","journal-title":"World J Cardiol"},{"key":"10.1016\/j.jacl.2021.11.014_bib0025","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1097\/PSY.0000000000000115","article-title":"Post-myocardial infarction anxiety or depressive symptoms and risk of new cardiovascular events or death: a population-based longitudinal study","volume":"76","author":"Larsen","year":"2014","journal-title":"Psychosom Med"},{"key":"10.1016\/j.jacl.2021.11.014_bib0026","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1177\/2047487313505244","article-title":"Anxiety is associated with a reduction in both mortality and major adverse cardiovascular events five years after coronary stenting","volume":"22","author":"Meyer","year":"2015","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.jacl.2021.11.014_bib0027","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.jpsychores.2018.03.170","article-title":"Anxiety, depression, and health-related quality of life in heterozygous familial hypercholesterolemia: A systematic review and meta-analysis","volume":"109","author":"Akioyamen","year":"2018","journal-title":"J Psychosom Res"},{"key":"10.1016\/j.jacl.2021.11.014_bib0028","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000100","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration","volume":"6","author":"Liberati","year":"2009","journal-title":"PLoS Med"},{"key":"10.1016\/j.jacl.2021.11.014_bib0029","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.jacl.2021.11.014_bib0030","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.jclinepi.2016.01.002","article-title":"Extracting data from figures with software was faster, with higher interrater reliability than manual extraction","volume":"74","author":"Jelicic Kadic","year":"2016","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.jacl.2021.11.014_bib0031","year":"2016","journal-title":"Cochrane Handbook for Systematic Reviews of Interventions"},{"key":"10.1016\/j.jacl.2021.11.014_bib0032","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Control. Clin. Trials."},{"key":"10.1016\/j.jacl.2021.11.014_bib0033","first-page":"20","author":"Cohen","year":"1988","journal-title":"Statistical Power Analysis for the Behavioral Sciences"},{"key":"10.1016\/j.jacl.2021.11.014_bib0034","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.jacl.2021.11.014_bib0035","series-title":"Review Manager (RevMan)","year":"2014"},{"key":"10.1016\/j.jacl.2021.11.014_bib0036","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.atherosclerosissup.2014.07.006","article-title":"Daily life, experience and needs of persons suffering from homozygous familial hypercholesterolaemia: insights from a patient survey","volume":"15","author":"Bruckert","year":"2014","journal-title":"Atheroscler Suppl"},{"key":"10.1016\/j.jacl.2021.11.014_bib0037","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.jacl.2012.03.004","article-title":"Apheresis in homozygous familial hypercholesterolemia: the results of a follow-up of all Norwegian patients with homozygous familial hypercholesterolemia","volume":"6","author":"Gr\u00e6sdal","year":"2012","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.jacl.2021.11.014_bib0038","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.jacl.2019.02.001","article-title":"Clinical management, psychosocial characteristics, and quality of life in patients with homozygous familial hypercholesterolemia undergoing LDL-apheresis in Turkey: Results of a nationwide survey (A-HIT1 registry)","volume":"13","author":"Kayikcioglu","year":"2019","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.jacl.2021.11.014_bib0039","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1016\/j.jacl.2016.05.006","article-title":"Ten years of lipoprotein apheresis for familial hypercholesterolemia in Malaysia: a creative approach by a cardiologist in a developing country","volume":"10","author":"Khoo","year":"2016","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.jacl.2021.11.014_bib0040","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1002\/jca.21839","article-title":"Lipoprotein apheresis and PCSK9 inhibitors for severe familial hypercholesterolaemia: experience from Australia and New Zealand","volume":"36","author":"Page","year":"2021","journal-title":"J Clin. Apheresis."},{"key":"10.1016\/j.jacl.2021.11.014_bib0041","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/j.jacl.2016.08.006","article-title":"Disease control via intensified lipoprotein apheresis in three siblings with familial hypercholesterolemia","volume":"10","author":"Taylan","year":"2016","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.jacl.2021.11.014_bib0042","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.jacl.2020.04.006","article-title":"Mental status and physical activity in patients with homozygous familial hypercholesterolemia: A subgroup analysis of a nationwide survey (A-HIT1 registry)","volume":"14","author":"Tun\u00e7el","year":"2020","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.jacl.2021.11.014_bib0043","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jad.2016.07.033","article-title":"Depression and serum low-density lipoprotein: A systematic review and meta-analysis","volume":"206","author":"Persons","year":"2016","journal-title":"J Affect Disord"},{"key":"10.1016\/j.jacl.2021.11.014_bib0044","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1503\/jpn.150079","article-title":"Serum lipid levels and suicidality: a meta-analysis of 65 epidemiological studies","volume":"41","author":"Wu","year":"2016","journal-title":"J Psychiatry Neurosci JPN"},{"key":"10.1016\/j.jacl.2021.11.014_bib0045","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1186\/1471-2458-12-624","article-title":"Physical activity and health related quality of life","volume":"12","author":"Anokye","year":"2012","journal-title":"BMC Public Health"},{"key":"10.1016\/j.jacl.2021.11.014_bib0046","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.jneb.2013.09.005","article-title":"Dietary interventions and quality of life: a systematic review of the literature","volume":"46","author":"Carson","year":"2014","journal-title":"J Nutr Educ Behav"},{"key":"10.1016\/j.jacl.2021.11.014_bib0047","first-page":"298","article-title":"Effect of psychological intervention on health-related quality of life in people with systemic lupus erythematosus: a systematic review","volume":"1","author":"Liang","year":"2014","journal-title":"Int J Nurs Sci"},{"key":"10.1016\/j.jacl.2021.11.014_bib0048","doi-asserted-by":"crossref","first-page":"g1151","DOI":"10.1136\/bmj.g1151","article-title":"Change in mental health after smoking cessation: systematic review and meta-analysis","volume":"348","author":"Taylor","year":"2014","journal-title":"BMJ"},{"key":"10.1016\/j.jacl.2021.11.014_bib0049","article-title":"Psychological interventions for coronary heart disease","volume":"4","author":"Richards","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jacl.2021.11.014_bib0050","first-page":"A245","article-title":"Abstract 245: demonstrating the effectiveness of an outpatient occupational therapy program for individuals with heart failure","volume":"10","author":"Olivia","year":"2017","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.jacl.2021.11.014_bib0051","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1177\/1077558716666981","article-title":"Higher hospital spending on occupational therapy is associated with lower readmission rates","volume":"74","author":"Rogers","year":"2017","journal-title":"Med Care Res Rev"},{"key":"10.1016\/j.jacl.2021.11.014_bib0052","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2017-016461","article-title":"Estimating the prevalence of heterozygous familial hypercholesterolaemia: a systematic review and meta-analysis","volume":"7","author":"Akioyamen","year":"2017","journal-title":"BMJ Open"},{"key":"10.1016\/j.jacl.2021.11.014_bib0053","first-page":"1210","article-title":"Simplified Canadian Definition for Familial Hypercholesterolemia","volume":"34","author":"Ruel","year":"2018","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.jacl.2021.11.014_bib0054","article-title":"Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC)","volume":"0","author":"Vallejo-Vaz","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.jacl.2021.11.014_bib0055","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S1567-5688(09)71804-5","article-title":"Extracorporeal LDL cholesterol elimination (25 years of experience in CZ)","volume":"10","author":"Blaha","year":"2009","journal-title":"Atheroscler Suppl"},{"key":"10.1016\/j.jacl.2021.11.014_bib0056","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.atherosclerosissup.2015.02.035","article-title":"Mental symptoms and quality of life in lipoprotein apheresis patients in comparison to hemodialysis patients, platelet donors and normal population","volume":"18","author":"Stasiewski","year":"2015","journal-title":"Atheroscler Suppl"},{"key":"10.1016\/j.jacl.2021.11.014_bib0057","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jacl.2010.11.003","article-title":"Patient tolerance regarding different low-density lipoprotein apheresis columns: frequent minor side effects and high patient satisfaction","volume":"5","author":"Hovland","year":"2011","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.jacl.2021.11.014_bib0058","first-page":"27","article-title":"WAA apheresis registry in the Czech Republic: two centers experience, Transfus","volume":"41","author":"Bl\u00e1ha","year":"2009","journal-title":"Apher Sci Off J World Apher Assoc Off J Eur Soc Haemapheresis"},{"key":"10.1016\/j.jacl.2021.11.014_bib0059","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1161\/CIRCULATIONAHA.117.028208","article-title":"Long-term efficacy and safety of the microsomal triglyceride transfer protein inhibitor lomitapide in patients with homozygous familial hypercholesterolemia","volume":"136","author":"Blom","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.jacl.2021.11.014_bib0060","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1056\/NEJMoa2004215","article-title":"Evinacumab for Homozygous Familial Hypercholesterolemia","volume":"383","author":"Raal","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacl.2021.11.014_bib0061","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/S0140-6736(10)60284-X","article-title":"Mipomersen, an apolipoprotein B synthesis inhibitor, for lowering of LDL cholesterol concentrations in patients with homozygous familial hypercholesterolaemia: a randomised, double-blind, placebo-controlled trial","volume":"375","author":"Raal","year":"2010","journal-title":"Lancet"}],"container-title":["Journal of Clinical Lipidology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287421003457?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287421003457?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T13:36:52Z","timestamp":1761831412000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1933287421003457"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":61,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["S1933287421003457"],"URL":"https:\/\/doi.org\/10.1016\/j.jacl.2021.11.014","relation":{},"ISSN":["1933-2874"],"issn-type":[{"value":"1933-2874","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Health-related quality of life in homozygous familial hypercholesterolemia: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Lipidology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacl.2021.11.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 National Lipid Association. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}